1. Home
  2. AYTU vs GFAI Comparison

AYTU vs GFAI Comparison

Compare AYTU & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • GFAI
  • Stock Information
  • Founded
  • AYTU N/A
  • GFAI 2018
  • Country
  • AYTU United States
  • GFAI Singapore
  • Employees
  • AYTU N/A
  • GFAI N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • AYTU Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • AYTU 23.0M
  • GFAI 19.1M
  • IPO Year
  • AYTU N/A
  • GFAI N/A
  • Fundamental
  • Price
  • AYTU $2.10
  • GFAI $0.83
  • Analyst Decision
  • AYTU Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • AYTU 3
  • GFAI 1
  • Target Price
  • AYTU $9.17
  • GFAI $4.50
  • AVG Volume (30 Days)
  • AYTU 62.6K
  • GFAI 381.2K
  • Earning Date
  • AYTU 11-13-2025
  • GFAI 09-23-2025
  • Dividend Yield
  • AYTU N/A
  • GFAI N/A
  • EPS Growth
  • AYTU N/A
  • GFAI N/A
  • EPS
  • AYTU N/A
  • GFAI N/A
  • Revenue
  • AYTU $66,382,000.00
  • GFAI $36,987,715.00
  • Revenue This Year
  • AYTU N/A
  • GFAI $5.66
  • Revenue Next Year
  • AYTU $29.12
  • GFAI $4.69
  • P/E Ratio
  • AYTU N/A
  • GFAI N/A
  • Revenue Growth
  • AYTU 1.84
  • GFAI 4.38
  • 52 Week Low
  • AYTU $0.95
  • GFAI $0.76
  • 52 Week High
  • AYTU $2.82
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 41.10
  • GFAI 33.59
  • Support Level
  • AYTU $2.01
  • GFAI $0.85
  • Resistance Level
  • AYTU $2.18
  • GFAI $0.93
  • Average True Range (ATR)
  • AYTU 0.13
  • GFAI 0.07
  • MACD
  • AYTU -0.02
  • GFAI -0.01
  • Stochastic Oscillator
  • AYTU 50.98
  • GFAI 6.44

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: